Blood letting in high-ferritin type 2 diabetes: Effects on vascular reactivity

Diabetes Care

Volumn 25, Issue 12, 2002, Pages 2249-2255

  Fernández Real, José Manuel ^a   Penarroja, Georgina ^a   Castro, Antoni ^a   García Bragado, Fernando ^a   López Bermejo, Abel ^a   Ricart, Wifredo ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; FERRITIN; GLYCERYL TRINITRATE; HEMOGLOBIN A1C; IRON; TRANSFERRIN;

AGE DISTRIBUTION; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VOLUME; BODY MASS; CHRONIC DISEASE; CIRCULATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM; FERRITIN BLOOD LEVEL; GENDER; HUMAN; IRON DEPLETION; IRON STORAGE; MALE; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT DEPARTMENT; PHLEBOTOMY; PREDICTION; RANDOMIZATION; ULTRASOUND; VASCULAR DISEASE; VASODILATATION; BLOOD; BLOOD FLOW VELOCITY; BLOOD SAMPLING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM;

BLOOD FLOW VELOCITY; BLOOD GLUCOSE; BLOOD SPECIMEN COLLECTION; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FERRITINS; HUMANS; IRON; MIDDLE AGED; NITROGLYCERIN; VASODILATION;

EID: 1842852523     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.12.2249     Document Type: Article

References (51)

1. Pang J, Jiang MJ, Chen YL, Wang FW, Wang DL, Chu SH: Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest 97:2204-2212, 1996
2. Abdalla DSP, Campa A, Monteiro MP: Low density lipoprotein oxidation by stimulated neutrophils and ferritin. Atherosclerosis 97:149-159, 1992
3. Hattori Y, Kawasaki H, Abe K, Kanno M: Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 261:H1086-H1094, 1991
4. Langenstroer P, Pieper GM: Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am J Physiol 263:H257-H265, 1992
5. Diederich D, Skopec J, Diederich A, Dai FX: Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol 266:H1153-H1161, 1994
6. Rōsen P, Ballhausen T, Bloch W, Addicks K: Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant. Diabetologia 38:1157-1168, 1995
7. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA: Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 97:22-28, 1996
8. Goodfellow J, Ramsey MW, Luddington LA, Jones CJ, Coates PA, Dunstan F, Lewis MJ, Owens DR, Henderson AH: Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin-dependent diabetes. BMJ 312:744-745, 1996
9. Williams SB, Cusco JA, Roddy M-A, Johnstone MT, Creager MA: Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 27:567-574, 1996
10. Vehkavaara S, Mäkimattila S, Schlenzka A, Vakkilainen J, Westerbacka J, Yki-Jarvinen H: Insulin therapy improves endothelial function in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 20:545-550, 2000
11. Lekakis J, Papamicheal C, Stamatelopoulos K, Cimponeriu A, Voutsas A, Vemmos K, Mavrikakis M, Stamatelopoulos S: Hemochromatosis associated with endothelial dysfunction: evidence for the role of iron stores in early atherogenesis. Vasc Med 4:147-148, 1999
12. Araujo JA, Romano EL, Brito BE, Parthe V, Romano M, Bracho M, Montano RF, Cardier J: Iron overload augments the development of atherosclerotic lesions in rabbits. Arterioscler Thromb Vasc Biol 15:1172-1180, 1995
13. Jacob HS: Newly recognized causes of atherosclerosis: the role of microorganisms and vascular iron overload. J Lab Clin Med 123:808-816, 1994
14. Failla M, Giannattasio C, Piperno A, Vergani A, Grappiolo A, Gentile G, Meles E, Mancia G: Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy. Hepatology 32:569-573, 2000
15. Cardoso LEM, Mourao PAS: Compositional and structural alterations of glycosaminglycans associated with the complications brought about by thalassemia major: a case report. Angiology 47:175-183, 1996
16. Rao GN, Berk BC: Active oxygen species stimulate vascular smooth muscle cell growth and protooncogene expression. Circ Res 70:593-599, 1992
17. Porreca E, Ucchino S, Di Febbo C, Di Bartolomeo N, Angelucci D, Napolitano AM, Mezzetti A, Cuccurullo F: Antiproliferative effect of desferrioxamine on vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb Vasc Biol 14:299-304, 1994
18. Pieper GM, Siebeneich W: Diabetes-induced endothelial dysfunction is prevented by long-term treatment with the modified iron chelator, hydroxyethyl starch conjugated-deferoxamine. J Cardiovasc Pharmacol 30:734-738, 1997
19. Nitenberg A, Paycha F, Ledoux S, Sachs R, Attali J-R, Valensi P: Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors. Circulation 97:736-743, 1998
20. Duffy SJ, Biegelsen ES, Holbrook M, Russell JD, Gokce N, Keaney JF Jr, Vita JA: Iron chelation improves endothelial function in patients with coronary artery disease. Circulation 103:2799-2804, 2001
21. Bofill C, Joven J, Bages C, Vilella E, Sans T, Cavalle P, Miralles R, Llobet J, Camps J: Response to repeated phlebotomies in patients with non-insulin-dependent diabetes mellitus. Metabolism 43:614-620, 1994
22. Salonen JT, Korpela H, Nyyssönen K, Porkkala E, Tuomainen TP, Belcher JD, Jacobs DR Jr, Salonen R: Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross-over trial in male smokers. J Intern Med 237:161-168, 1995
23. Galle J, Bauersachs J, Busse R, Bassenge E: Inhibition of cyclic AMP- and cyclic GMP-mediated dilations in isolated arteries by oxidized low density lipoproteins. Arterioscler Thromb 12:180-186, 1992
24. Eben RV, Stead EA, Gibson JG: Response of normal subjects to acute blood loss. Arch Intern Med 68:578-590, 1941
25. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111-1115, 1992
26. Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand J: Ultrasound measurements of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol 11:565-577, 1991
27. Buga GM, Gold ME, Fukuto JM, Ignarro LJ: Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 17:187-193, 1991
28. Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407-420, 1990
29. Cameron NE, Cotter MA: Effects of an extracellular metal chelator on neurovascular function in diabetic rats. Diabetologia 44:621-628, 2001
30. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87:1620-1624, 1990
31. Angulo J, Sánchez-Ferrer CF, Peiró C, Marín J, Rodriguez-Mañas L: Impairment of endothelium-dependent relaxation by increasing percentages of glycosylated human hemoglobin: possible mechanisms involved. Hypertension 28:583-592, 1996
32. Faivre-Fiorina B, Caron A, Fassot C, Fries I, Menu P, Labrude P, Vigneron C: Presence of hemoglobin inside aortic cells after cell-free hemoglobin administration in guinea-pigs. Am J Physiol 276:H766-H770, 1999
33. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW, Hayes JR: Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:771-776, 1992
34. Watts GF, O'Brien SF, Silvester W, Millar JA: Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidemia. Clin Sci 91:567-573, 1996
35. Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE, Celermajer DS: Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 32:123-127, 1998
36. Cutler P: Deferoxamine therapy in high-ferritin diabetes. Diabetes 38:1207-1210, 1989
37. Redmon JB, Pyzdrowski KL, Robertson RP: No effect of deferoxamine therapy on glucose homeostasis and insulin secretion in individuals with NIDDM and elevated serum ferritin. Diabetes 42:544-549, 1993
38. Facchini FS: Effect of phlebotomy on plasma glucose and insulin concentrations (Letter). Diabetes Care 21:2190, 1998
39. Wolff SP, Jiany ZY, Hunt JV: Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radic Biol Med 10:339-352, 1991
40. Fernández-Real JM, Ricart W, Arroyo E, Balança R, Casamitjana R, Cabrero D, Fernández-Castañer M, Soler J: Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 21:62-68, 1998
41. Tuomainen T-P, Nyysönen K, Salonen R, Tervahauta A, Korpela H, Lakka T, Kaplan GA, Salonen JT: Body iron stores are associated with serum insulin and blood glucose concentrations. Diabetes Care 20:426-428, 1997, 1996
42. Salonen JT, Tuomainen T-P, Nyyssōnen K, Lakka H-M, Punnonen K: Relation between iron stores and non-insulin-dependent diabetes in men: case-control study. BMJ 317:727-730, 1998
43. Ford ES, Cogswell ME: Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care 22:1978-1983, 1999
44. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ: Blood donations and risk of coronary heart disease in men. Circulation 103:52-57, 2001
45. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW: Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 332:481-487, 1995
46. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P: The effect of cholesterol lowering and antioxidant therapy on endothelium-dependent coronary vasodilation. N Engl J Med 332:488-493, 1995
47. Clarkson P, Adams MR, Powe AJ, Donald AE, McCredie R, Robinson J, McCarthy SN, Keech A, Celermajer DS, Deanfield JE: Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest 97:1989-1994, 1996
48. Mancini GB, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Luscher TF, Klibaner MI, Haber HE, Uprichard AC, Pepine CJ, Pitt B: Angiotensin-converting enzyme: inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 94:258-265, 1996
49. Gilligan DM, Quyyumi AA, Cannon RO: Effects of physiological levels of estrogen on coronary vasomotor function in post-menopausal women. Circulation 89:2545-2551, 1994
50. Levine GN, Frei B, Kouloukis SN, Gerhard MO, Keaney JFJ, Vita JA: Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 93:1107-1113, 1996
51. Butler R, Morris AD, Belch JJF, Hill A, Struthers AD: Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35:746-751, 2000